🩸 Hypoglycemia Counter-Regulation Simulator
An interactive model of hormonal counter-regulation during hypoglycemia (glucagon, adrenaline, cortisol) with a demonstration of impaired hypoglycemia recognition in long-term diabetes.
Blood Glucose Begins Dropping
Glucose falls toward the hypoglycemic threshold, priming the defense response.
- 70–99: Normal fasting glucose (mg/dL)
- ~70: Counter-reg. threshold (mg/dL onset)
- <54: Danger threshold (mg/dL, symptoms marked)
- <40: Severe threshold (mg/dL, cognitive risk)
Why glucose falls
Insulin, delayed meals, or exercise lower circulating glucose levels.
The body senses the drop
Pancreatic and hypothalamic sensors detect falling glucose quickly.
Defense cascade primed
Falling glucose below threshold triggers hormonal counter-regulation.
Glucagon Then Epinephrine Activate
Glucagon leads, epinephrine follows, producing the classic warning symptoms.
- Pancreatic α-cells: Glucagon source (first responder)
- Hepatic glycogenolysis: Glucagon action (glucose release)
- Adrenal medulla: Epinephrine source (second responder)
- Shaky · sweaty · palpitations: Epi symptoms (autonomic warning)
Glucagon fires first
Glucagon rapidly signals the liver to release stored glucose.
Epinephrine follows
Adrenaline adds glucose release and produces warning symptoms.
Symptoms as an alarm
Shakiness and sweating prompt the person to eat quickly.
Cortisol Adds Slower, Lasting Support
Cortisol reinforces glucose recovery over a longer, slower timescale.
- Adrenal cortex: Cortisol source (third responder)
- ~30–60 min: Onset delay (slower than epinephrine)
- Gluconeogenesis support: Action (sustained glucose output)
- Hours: Duration (prolonged effect)
A slower third layer
Cortisol builds gradually, reinforcing earlier hormone actions.
Sustained glucose output
It supports glucose production over a longer recovery window.
Full healthy cascade
Together, three hormones restore glucose reliably and safely.
The Cascade Weakens Over Time
Repeated hypoglycemia progressively dulls glucagon, then epinephrine, responses.
- Glucagon: First to blunt (often lost early in T1D)
- Epinephrine: Second to blunt (weakens with repetition)
- Recurrent hypoglycemia: Driver (antecedent episodes)
- Reduced defense: Result (slower glucose recovery)
Glucagon fails first
Long-standing diabetes often abolishes the glucagon response early.
Epinephrine weakens next
Repeated lows blunt adrenaline release and its symptoms.
A vicious cycle
Each hypoglycemic episode further blunts the next response.
Hypoglycemia Unawareness
Blunted hormones and lost symptoms leave glucose lows unrecognized and dangerous.
- ~25%: Prevalence in T1D (long-duration patients)
- 6× higher: Severe hypo risk (with unawareness)
- Partial: Reversibility (with strict avoidance of lows)
- Avoid recurrent lows: Key strategy (restores some awareness)
Unawareness defined
No warning symptoms occur before glucose drops dangerously low.
Why it is dangerous
Without symptoms, severe hypoglycemia can occur without warning.
Managing the risk
Careful glucose targets and monitoring can partly restore awareness.
Counter-regulatory hormones at a glance
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Glucagon | Liver (hepatocytes) | Stimulates glycogenolysis, first and fastest responder | Often blunted earliest in long-standing diabetes |
| Epinephrine | Liver, muscle, adipose | Drives glycogenolysis plus autonomic warning symptoms | Loss removes the felt warning signs |
| Cortisol | Liver (gluconeogenesis) | Slow, sustained glucose output over hours | Reinforces recovery once activated |
| Awareness signal | Central nervous system | Perception of adrenergic symptoms as a warning | Prompts corrective carbohydrate intake |
An interactive model of hormonal counter-regulation during hypoglycemia (glucagon, adrenaline, cortisol) with a demonstration of impaired hypoglycemia recognition in long-term diabetes.
2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install